The ability of prescription drugs and medical procedures to improve intellectual performance is likely to increase significantly in the next 20 to 30 years as technology advances.
“We know that there is likely to be a demand by healthy individuals for this treatment,” Dr Tony Calland, chairman of the BMA’s Medical Ethics Committee said at the launch of a discussion paper on the issue. “However, given that no drug or invasive medical procedure is risk free, is it ethical to make them available to people who are not ill?”
Surreptitious use of brain-boosting prescription drugs is particularly common in the United States and likely to increase in Britain, the BMA said…
Today, the use of pharmaceutical aids to boost performance is mainly confined to certain groups — notably students cramming for exams.Popular choices include drugs for attention deficit hyperactivity disorder, such as Ritalin, or methylphenidate, made by Novartis AG and others.Another favorite is modafinil, the active ingredient in Cephalon Inc’s narcolepsy medicine Provigil…’ (Scientific American)
The fallacy in this concern is that we can ever effectively decide whether a given person is ill or just well and cheating. The boundaries of illness are social constructions dependent on cultural norms. It is easy to point to the enormous influence of the profit-driven pharmaceutical industry but I think our collective mental ecology is being betrayed by psychiatrists and other metal health professionals who should be smart enough to know better. Pharmacological determinism has gone fist in glove with medicalizing and pathologizing personality traits and normal human variability.

